Prognostic factors in patients with advanced non-small cell lung cancer: data from the phase III FLEX study.

Prognostic factors in patients with advanced non-small cell lung cancer: data from the phase III FLEX study.

Item
http://www.wikidata.org/entity/Q34231171
Advanced gastric cancer: Current treatment landscape and future perspectivesRandomized phase II study of pemetrexed/cisplatin with or without axitinib for non-squamous non-small-cell lung cancerTumor response and clinical toxicity associated with second-line chemotherapy regimens for advanced non-squamous non-small cell lung cancer: A retrospective cohort study.Predicting Survival in Patients with Advanced Non-squamous Non-small Cell Lung Cancer: Validating the Extent of MetastasisMolecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of Individualized TherapyTobacco use in the oncology setting: advancing clinical practice and researchThe association between clinical prognostic factors and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer patients: a retrospective assessment of 94 cases with EGFR mutations.Single pemetrexed is noninferior to platinum-based pemetrexed doublet as first-line treatment on elderly Chinese patients with advanced nonsquamous nonsmall cell lung cancer.Monoclonal antibodies in lung cancer.Innovative personalized medicine in gastric cancer: time to move forward.The biological and clinical effects of smoking by patients with cancer and strategies to implement evidence-based tobacco cessation support.Risk factors and management of oligometastatic non-small cell lung cancer.Combining three antibodies nullifies feedback-mediated resistance to erlotinib in lung cancer.Targeted therapies for the treatment of non-small-cell lung cancer: Monoclonal antibodies and biological inhibitors.Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer.Prognostic factors in patients with skeletal-related events at non-small-cell lung cancer diagnosis.Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung c
P2860

Prognostic factors in patients with advanced non-small cell lung cancer: data from the phase III FLEX study.

Item
http://www.wikidata.org/entity/Q34231171
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Prognostic factors in patients ...... from the phase III FLEX study.
@ast
Prognostic factors in patients ...... from the phase III FLEX study.
@en
Prognostic factors in patients ...... from the phase III FLEX study.
@nl
type
label
Prognostic factors in patients ...... from the phase III FLEX study.
@ast
Prognostic factors in patients ...... from the phase III FLEX study.
@en
Prognostic factors in patients ...... from the phase III FLEX study.
@nl
prefLabel
Prognostic factors in patients ...... from the phase III FLEX study.
@ast
Prognostic factors in patients ...... from the phase III FLEX study.
@en
Prognostic factors in patients ...... from the phase III FLEX study.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Prognostic factors in patients ...... from the phase III FLEX study.
@en
P2093
P304
P31
P356
10.1016/J.LUNGCAN.2012.03.010
P433
P478
P50
P577
P698